Re: Cervical cancer: WHO called for elimination, not eradication
Publication date: Available online 19 November 2019Source: Gynecologic Oncology ReportsAuthor(s): Emily S. Wu, Renata R. Urban, Elizabeth M. Krantz, Noleb M. Mugisha, Carolyn Nakisige, Stephen M. Schwartz, Heidi J. Gray, Corey CasperAbstractOur objective was to determine how HIV infection impacts cervical cancer stage at presentation and overall survival (OS) among Ugandan women. This was a prospective study of 149 women diagnosed with cervical cancer from 2013-2015 at the Uganda Cancer Institute. Poisson regression models were fit to calculate prevalence ratios (PR) for the association between HIV infection and late stage...
Screening rates are insufficient to reduce cervical cancer incidence
Authors: Feng Y, Liu H, Ding Y, Zhang Y, Liao C, Jin Y, Ai C Abstract PURPOSE: To prospectively investigate changes in quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and the apparent diffusion coefficient (ADC) of diffusion-weighted imaging (DWI) in patients with cervical cancer before and after neoadjuvant chemotherapy (NACT). METHODS: Thirty-eight patients with cervical cancer underwent DCE-MRI and DWI 1 week before and 4 weeks after NACT. The patients were classified into 2 groups: significant reaction (sCR) group and the non-sCR group. DCE-MRI parameters and ADC va...
TUESDAY, Nov. 19, 2019 -- Cervical cancer screening rates are only about 70 percent among women ages 45 to 65 years, according to a study published online Nov. 1 in Preventive Medicine. Diane M. Harper, M.D., from the University of Michigan in Ann...
(National Centre for Biological Sciences) A recent paper from the lab of Professor Sudhir Krishna at the National Centre for Biological Sciences, Bangalore, reviews the progress made in cervical cancer research over the past 25 years. This extensive coverage published in the journal of Experimental Cell Research highlights the role of a popular signaling molecule called Notch in human cervical cancer progression.
Authors: Demers AA, Brenner DR, Smith L, Shaw A Abstract Examining incidence trends of all cancers combined in order to understand cancer trends can be misleading, as patterns can vary across individual cancer types. This paper highlights findings on trends over time from Canadian Cancer Statistics 2019, as measured by the annual percent change (APC) of age-standardized incidence rates. Among the results were a recent increase in thyroid cancer in males (APC: 6.4%, 1997-2015), as well as decreases in prostate cancer (APC: -9.1%, 2011-2015) and cervical cancer (APC: -3.3%, 2010-2015). PMID: 31729314 [PubMed - in process]
Publication date: December 2019Source: American Journal of Preventive Medicine, Volume 57, Issue 6Author(s):
ConclusionsPractical difficulties in quantifying quality of life losses and healthcare expenditures owing to competing risks in life years gained can be overcome. Their inclusion can have a substantial impact on the cost-effectiveness of cancer screening programs.
ConclusionsA considerable proportion of women did not have adequate prior screening by age 65 years. Of these, a large proportion did not receive screening after age 65 years, except those who had a recent abnormal screening result. Further research is needed to understand barriers for guideline adherence and rationales for clinical decision making.